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Introduction
Infective endocarditis (IE) is still a serious medical
problem. It not only carries significant mortality
during the actual period of endocardial infection, but
causes morbidity that may persist beyond the duration
of active infection. Complications such as heart
failure, neurological deficits following central nervous
system embolism, complications of heart surgery or
anticoagulation following valve replacement are
considerable. Thus it is clear that everything should
be done to prevent IE. However, the development of
prophylactic measures implies a precise knowledge of
the pathogenesis of this disease.
Unfortunately, many questions regarding the
pathogenesis and the prophylaxis of IE in humans
remain unanswered; these include the precise sequence
of events in the establishment of human endocarditis
as well as the actual risk of a given invasive procedure
to cause transient bacteraemia and endocarditis.
Moreover, even the actual risk of development of
endocarditis for a given underlying cardiac condition
is uncertain and controversial. These and similar
questions could only be answered by controlled
clinical trials. However, it is unlikely that such clinical
studies will be performed, mainly because the number
of patients required would be too large1''. One
approach to partially solving these questions is a
better understanding of the pathogenesis of IE as seen
in experimental models; this may lead to a better
rationale for prophylactic recommendations in
Description of experimental models
Freedman and coworkers originally developed a
rabbit model of endocarditis whose rationale was
derived from clinical observations121. They noted the
ease with which intravenous polyethylene catheters
became secondarily infected, resulting in bacteraemia
in several patients. They also observed that their
patients with catheter-induced sepsis had developed
infective endocarditis at the point of contact of the
indwelling central venous catheter in the right auricle.
They therefore introduced a polyethylene catheter into
the right and left heart of rabbits, filling the catheter
with microorganisms. Durack et al.m changed the
model somewhat in that they injected the bacteria
intravenously, which resulted in a high incidence of
tricuspid or aortic valve endocarditis14'. Following a
similar technique we have recently developed a model
in rats, which will be briefly described'5'.
A polyethylene catheter is inserted across the aortic
valve through the right carotid artery, resulting in the
production of sterile valvular vegetations. These
endocardial lesions resemble those found in humans
after diseases such as rheumatic fever13-"'. Twenty-four
hours after catheterization rats are injected in the tail
vein with a given bacterial inoculum of the test
organism. The rats are sacrificed at varying time
intervals after i.v. bacterial challenge; quantitative
blood cultures are then drawn, the aortic vegetations
are excised, weighed, homogenized, serially diluted
and plated. Plates are counted after 48-72 hours of
incubation.
Antibiotic prophylaxis is performed by injecting
one group of rats with a given dosage of the selected
antibiotic at different time intervals before bacterial
challenge. The dosage and time intervals are chosen
so as to result in peak serum levels in rats similar to
those in humans after a recommended dose at the time
the organisms are injected.
The relevance of these experimental models to the
human situation has been questioned mainly for two
reasons1'1.
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Figure I Quantitative determination of bacterial numbers
circulating in the blood (log10 c.f.u. ml"') of rats at different
times after i.v. challenge with 104 c.f.u. of either S. inlermedius
(o), a viridans streptococcal strain, or S. faecalis 1209 (•).
Each circle represents values from one rat.
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Figure 2 Incidence of endocarditis in rats 3
days after i.v. challenge with I04 c.f.u. of either
5. inlermedius or S.faecalis 1209. The number
of rats with infected vegetations / total
number of injected rats is indicated at the base
of each column.
THE RELEVANCE OF THE INTRACARDIAC CATHETER
In most experimental studies the catheter has been
left in place throughout the whole experiment, while
most frequently there is no intravascular foreign body
present in humans. There is experimental evidence,
however, that the persistence of the catheter favours
the development of IE18-91, and that antibiotic
prophylaxis is facilitated when the catheter is
removed151. Thus, experimental models for the
prophylaxis of endocarditis with a catheter in place
provide a very stringent test of antibiotic prophylaxis.
Furthermore, one may argue that it mimics clinical
situations in humans with prosthetic heart valves or
other intravascular foreign bodies.
THE MAGNITUDE OF THE BACTERAEMIA USED FOR
BACTERIAL CHALLENGE
The magnitude of the bacterial inocula injected i.v.
to the animals (104-108 c.f.u.) has been considered
irrelevant when compared to bacteraemias observed
in humans. Indeed, the magnitude of bacteraemia
observed in humans after certain procedures such as
teeth extractions is generally of the order of
lO'-lO2 c.f.u. ml"1 of blood for a given strain'101.
However, it must be kept in mind that i.v. bacterial
challenge in rats results in circulating bacterial
numbers that are far below the originally injected
inoculum, due both to a passive haemodilution effect
and to an active clearance mechanism by the
reticulo-endothelial system'111. Furthermore, it must
be emphasized that the relationship between the
magnitude of bacteraemia and the risk of subsequent
development of IE in humans is unknown. Indeed, it
is quite conceivable that those very patients who
develop endocarditis after a given procedure are
precisely those who presented the highest number of
circulating bacteria.
The properties of various bacterial strains to induce
endocarditis
The relationship between the magnitude of transient
bacteraemia and the subsequent development of
IE has been carefully investigated in the rat model
of IE. It has been shown that for a given i.v. inocu-
lum size of a test strain, the incidence of infection
3 days after challenge was fairly constant and
reproducible. Wide variations have been observed
between different bacterial strains in their ability to
induce endocarditis'12 141. Thus, the injection of
similar numbers of various strains does not induce ipso
facto the same incidence of endocarditis, although it
is likely to induce similar magnitudes of bacteraemias.
As an example, Fig. 1 shows the results of quantitative
blood cultures performed in groups of rats injected
with 104 c.f.u. of either an S. faecalis strain or a
viridans streptococcal strain (S. intermedius). As can
be seen, a similar number of S. faecalis and S.
intermedius colonies were circulating at different times
after i.v. challenge and all blood cultures were sterile
15 min after injection. Figure 2 shows the incidence of
IE due to both strains 3 days after bacterial challenge.
While the S.faecalis strain repeatedly infected 90% of
the animals (ID 90), only about one-half (58 %) of the
animals had S. intermedius endocarditis. Since the
clearance of both organisms from the blood was
similar, it implies that the two strains had different
pathogenic properties. Indeed, using a modified in
vitro assay first developed by Scheld el a/.'151, we could
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demonstrate that the S. faecalis strain adhered
significantly more to platelet-fibrin matrices in vitro
than the viridans streptococcal strain. Others have
shown similar results in vitro using punch biopsy
sections of human or canine aortic valve
endothelium1161.
More importantly, our recent studies on the
production of endocarditis in rats after the extraction
of periodontally diseased teeth have failed to
demonstrate a correlation between the total number
of a given streptococcal species that circulated
immediately after teeth extractions and the likelihood
that these streptococci will subsequently produce
endocarditis11'1. Indeed, some streptococcal strains
that circulated at barely detectable levels consistently
produced endocarditis, while other viridans strep-
tococci that were found in much higher numbers in
the blood after extractions only rarely infected the
valves. In these experiments, we could also show that
the stickiness in vitro of a given bacterial species for
platelet-fibrin matrices predicted best the likelihood
that this strain would produce IE. Thus the
determination of the magnitude of bacteraemia after
certain procedures alone is unlikely to provide reliable
information on the risk of subsequent development of
IE.
Conclusions
Experimental models of IE were developed as a
consequence of careful clinical observations. The
disease produced in experimental models is much like
the disease observed in humans. Moreover, the role of
an intravascular foreign body can be accurately
investigated. Experimental models of bacterial endo-
carditis offer several advantages for studying the
prevention of the disease: proper experimental
controls can be used and large numbers of animals can
be studied in order to achieve statistically significant
results.
More importantly, the model permits comparison
of the efficacy of various antibiotic regimes against
different organisms in vivo and will help unravel the
mode of action of prophylactic antibiotics, thus giving
a rationale for endocarditis prophylaxis recommen-
dations in humans which may provide a wide margin
of safety.
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